基于数据挖掘分析洪敏俐治疗慢性阻塞性肺疾病稳定期用药规律
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563

基金项目:

福建中医药大学校管课题临床专项(XB2022138);福建省名老中医药专家传承工作室建设项目(闽卫中医〔2023〕697号);福建省 2022年省级临床重点专科建设项目(闽卫医政函〔2022〕884号)


Analysis on Medication Rules of HONG Minli in Treating Stable Chronic Obstructive Pulmonary Disease Based on Data Mining
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:基于数据挖掘分析洪敏俐教授辨证治疗慢性阻塞性肺疾病稳定期的用药规律。方法:收集 2019年7月—2024年6月洪敏俐教授治疗慢性阻塞性肺疾病稳定期患者中药处方,将处方信息规范化处理后录 入中医传承辅助平台(V3.5) 建立数据库,采用该系统的统计分析、方剂分析模块对中药使用频次、四气、五 味、归经进行统计分析,对中药核心组合进行关联规则分析,并通过聚类分析提取核心组合处方。结果:共纳 入548首处方,涉及药物193味,使用频次排在前10位的药物是茯苓、甘草、半夏、白术、陈皮、党参、大 枣、桂枝、黄芪、黄芩。中药药性以温、平、寒性为主;中药药味以甘味、苦、辛味为主;中药归经以脾、 肺、胃、心、肾、肝经为主。药物关联规则分析得出核心药物组合支持度排前5位依次为甘草-半夏、甘草-茯 苓、甘草-白术、茯苓-白术、甘草-茯苓-白术,置信度排前4位的依次为“甘草,陈皮→茯苓”“茯苓,陈 皮→甘草”“半夏,陈皮→甘草”“甘草,陈皮→半夏”,网络拓扑图显示主要的核心药物为桂枝、半夏、茯苓、 陈皮、甘草、白术、大枣。k-means聚类分析得出6类核心处方:苓桂术甘汤合六君子汤加减、六君子汤加减、 苓甘五味姜辛汤合半夏泻心汤加减、六味地黄丸加减、柴胡类方加减、金水六君煎加减。结论:洪敏俐教授治 疗慢性阻塞性肺疾病稳定期患者用药以补虚为主,标本兼顾,攻补兼施,寒温并用。

    Abstract:

    Abstract: Objective: To analyze the medication rules of Professor HONG Minli in treating stable chronic obstructive pulmonary disease (COPD) by syndrome differentiation based on data mining. Methods:Professor HONG Minli´s Chinese medicine prescriptions for patients with stable COPD from July 2019 to June 2024 were collected and the prescription information was standardized and entered into the Traditional Chinese Medicine Inheritance Support System (V3.5) to establish a database. The modules of statistical analysis and prescription analysis in the system were used to analyze the use frequency, four qi, five flavors and meridian entries of Chinese medicinals. The core combinations of Chinese medicinals were given the association rules analysis, and the core combination prescriptions were extracted by the clustering analysis. Results:A total of 548 prescriptions were included,involving 193 Chinese medicinals. The top 10 Chinese medicinals were Poria, Glycyrrhizae Radix et Rhizoma, Pinelliae Rhizoma, Atractylodis Macrocephalae Rhizoma, Citri Reticulatae Pericarpium, Codonopsis Radix, Jujubae Fructus, Cinnamomi Ramulus, Astragali Radix and Scutellariae Radix. The nature of Chinese medicinals were mainly warm, neutral and cold; the flavors were mainly sweet, bitter and pungent; the meridian entries were mainly the spleen, lung, stomach, heart, kidney and liver. The association rule analysis showed that the top five core medicinal combinations ranked by support were Glycyrrhizae Radix et Rhizoma-Pinelliae Rhizoma, Glycyrrhizae Radix et Rhizoma-Poria, Glycyrrhizae Radix et Rhizoma-Atractylodis Macrocephalae Rhizoma, Poria-Atractylodis Macrocephalae Rhizoma,and Glycyrrhizae Radix et Rhizoma-Poria-Atractylodis Macrocephalae Rhizoma. The top four in confidence levels were “Glycyrrhizae Radix et Rhizoma, Citri Reticulatae Pericarpium→Poria”“Poria, Citri Reticulatae Pericarpium→Glycyrrhizae Radix et Rhizoma”“Pinelliae Rhizoma, Citri Reticulatae Pericarpium→ Glycyrrhizae Radix et Rhizoma” and “Glycyrrhizae Radix et Rhizoma, Citri Reticulatae Pericarpium→Pinelliae Rhizoma”. The network topology showed that the main core medicinals were Cinnamomi Ramulus,Pinelliae Rhizoma, Poria, Citri Reticulatae Pericarpium, Glycyrrhizae Radix et Rhizoma, Atractylodis Macrocephalae Rhizoma, and Jujubae Fructus. K-means cluster analysis showed six core prescriptions,including modified Linggui Zhugan Decoction combined with Liujunzi Decoction, modified Liujunzi Decoction, modified Linggan Wuwei Jiangxin Decoction combined with Banxia Xiexin Decoction, modified Liuwei Dihuang Pills, modified Chaihu associated Decoction and modified Jinshui Liujun Decoction. Conclusion: Professor HONG Minli mainly treats patients with stable COPD by Chinese medicinals for tonifying deficiency, dealing with both the root and branch of the disease, using methods of attack and supplement,and using both cold and warm medicinals.

    参考文献
    相似文献
    引证文献
引用本文

黄锦榕,林叶倩,指导:洪敏俐.基于数据挖掘分析洪敏俐治疗慢性阻塞性肺疾病稳定期用药规律[J].新中医,2025,57(10):8-13

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-05-27
  • 出版日期:
文章二维码